Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 152

1.

Quantitative fecal immunochemical tests for colorectal cancer screening.

Gies A, Bhardwaj M, Stock C, Schrotz-King P, Brenner H.

Int J Cancer. 2018 Jul 15;143(2):234-244. doi: 10.1002/ijc.31233. Epub 2018 Jan 12. Review.

PMID:
29277897
2.

Colonoscopy vs. Fecal Immunochemical Test in Reducing Mortality From Colorectal Cancer (CONFIRM): Rationale for Study Design.

Dominitz JA, Robertson DJ, Ahnen DJ, Allison JE, Antonelli M, Boardman KD, Ciarleglio M, Del Curto BJ, Huang GD, Imperiale TF, Larson MF, Lieberman D, O'Connor T, O'Leary TJ, Peduzzi P, Provenzale D, Shaukat A, Sultan S, Voorhees A, Wallace R, Guarino PD.

Am J Gastroenterol. 2017 Nov;112(11):1736-1746. doi: 10.1038/ajg.2017.286. Epub 2017 Oct 10.

PMID:
29016565
3.

A Comparison of Fecal Immunochemical and High-Sensitivity Guaiac Tests for Colorectal Cancer Screening.

Shapiro JA, Bobo JK, Church TR, Rex DK, Chovnick G, Thompson TD, Zauber AG, Lieberman D, Levin TR, Joseph DA, Nadel MR.

Am J Gastroenterol. 2017 Nov;112(11):1728-1735. doi: 10.1038/ajg.2017.285. Epub 2017 Oct 10.

PMID:
29016558
4.

Screening for Colorectal Cancer With Fecal Immunochemical Testing With and Without Postpolypectomy Surveillance Colonoscopy: A Cost-Effectiveness Analysis.

Greuter MJE, de Klerk CM, Meijer GA, Dekker E, Coupé VMH.

Ann Intern Med. 2017 Oct 17;167(8):544-554. doi: 10.7326/M16-2891. Epub 2017 Oct 3.

PMID:
28973514
5.

Direct Comparison of Diagnostic Performance of 9 Quantitative Fecal Immunochemical Tests for Colorectal Cancer Screening.

Gies A, Cuk K, Schrotz-King P, Brenner H.

Gastroenterology. 2018 Jan;154(1):93-104. doi: 10.1053/j.gastro.2017.09.018. Epub 2017 Sep 25.

6.

Population-based colorectal cancer screening programmes using a faecal immunochemical test: should faecal haemoglobin cut-offs differ by age and sex?

Arana-Arri E, Idigoras I, Uranga B, Pérez R, Irurzun A, Gutiérrez-Ibarluzea I, Fraser CG, Portillo I; EUSKOLON Group.

BMC Cancer. 2017 Aug 29;17(1):577. doi: 10.1186/s12885-017-3555-3.

7.

Diagnostic performance of flexible sigmoidoscopy combined with fecal immunochemical test in colorectal cancer screening: meta-analysis and modeling.

Niedermaier T, Weigl K, Hoffmeister M, Brenner H.

Eur J Epidemiol. 2017 Jun;32(6):481-493. doi: 10.1007/s10654-017-0279-2. Epub 2017 Jun 30. Review.

PMID:
28667446
8.

Colorectal cancer population screening programs worldwide in 2016: An update.

Navarro M, Nicolas A, Ferrandez A, Lanas A.

World J Gastroenterol. 2017 May 28;23(20):3632-3642. doi: 10.3748/wjg.v23.i20.3632. Review.

9.

Colorectal Cancer Screening: Recommendations for Physicians and Patients From the U.S. Multi-Society Task Force on Colorectal Cancer.

Rex DK, Boland CR, Dominitz JA, Giardiello FM, Johnson DA, Kaltenbach T, Levin TR, Lieberman D, Robertson DJ.

Gastroenterology. 2017 Jul;153(1):307-323. doi: 10.1053/j.gastro.2017.05.013. Epub 2017 Jun 9.

PMID:
28600072
10.

Interval Colorectal Cancer Incidence Among Subjects Undergoing Multiple Rounds of Fecal Immunochemical Testing.

van der Vlugt M, Grobbee EJ, Bossuyt PMM, Bos A, Bongers E, Spijker W, Kuipers EJ, Lansdorp-Vogelaar I, Spaander MCW, Dekker E.

Gastroenterology. 2017 Aug;153(2):439-447.e2. doi: 10.1053/j.gastro.2017.05.004. Epub 2017 May 5.

PMID:
28483499
11.

Early Adoption of a Multitarget Stool DNA Test for Colorectal Cancer Screening.

Finney Rutten LJ, Jacobson RM, Wilson PM, Jacobson DJ, Fan C, Kisiel JB, Sweetser S, Tulledge-Scheitel SM, St Sauver JL.

Mayo Clin Proc. 2017 May;92(5):726-733. doi: 10.1016/j.mayocp.2017.01.019.

12.

Which Fecal Immunochemical Test Should I Choose?

Daly JM, Xu Y, Levy BT.

J Prim Care Community Health. 2017 Oct;8(4):264-277. doi: 10.1177/2150131917705206. Epub 2017 Apr 27. Review.

13.

Evaluation of the Effectiveness and Cost-Effectiveness of Personalized Surveillance After Colorectal Adenomatous Polypectomy.

McFerran E, O'Mahony JF, Fallis R, McVicar D, Zauber AG, Kee F.

Epidemiol Rev. 2017 Jan 1;39(1):148-160. doi: 10.1093/epirev/mxx002. Review.

PMID:
28402402
14.

Screening for colorectal cancer.

Choi Y, Sateia HF, Peairs KS, Stewart RW.

Semin Oncol. 2017 Feb;44(1):34-44. doi: 10.1053/j.seminoncol.2017.02.002. Epub 2017 Feb 10. Review.

PMID:
28395761
15.

The fecal occult blood test as a tool for improved outpatient qualification for colonoscopy. A single-center experience and 10-year follow-up survey.

Banaszkiewicz Z, Budzyński J, Tojek K, Jarmocik P, Frasz J, Mrozowski M, Świtoński M, Jawień A.

Adv Med Sci. 2017 Mar;62(1):171-176. doi: 10.1016/j.advms.2016.08.003. Epub 2017 Mar 7.

PMID:
28282604
16.

Serological biomarkers in triage of FIT-positive subjects?

Nielsen HJ, Christensen IJ, Andersen B, Rasmussen M, Friis-Hansen LJ, Bygott T, MiCallef J; Danish–Belgian Research Group on Early Detection of Colorectal Cancer.

Scand J Gastroenterol. 2017 Jun - Jul;52(6-7):742-744. doi: 10.1080/00365521.2017.1299212. Epub 2017 Mar 8.

PMID:
28271924
17.

Multitarget stool DNA tests increases colorectal cancer screening among previously noncompliant Medicare patients.

Prince M, Lester L, Chiniwala R, Berger B.

World J Gastroenterol. 2017 Jan 21;23(3):464-471. doi: 10.3748/wjg.v23.i3.464.

18.

Replacing the Guaiac Fecal Occult Blood Test With the Fecal Immunochemical Test Increases Proportion of Individuals Screened in a Large Healthcare Setting.

Akram A, Juang D, Bustamante R, Liu L, Earles A, Ho SB, Wang-Rodriguez J, Allison JE, Gupta S.

Clin Gastroenterol Hepatol. 2017 Aug;15(8):1265-1270.e1. doi: 10.1016/j.cgh.2017.01.025. Epub 2017 Feb 4.

PMID:
28167157
19.

Comparative effectiveness of screening strategies for colorectal cancer.

Barzi A, Lenz HJ, Quinn DI, Sadeghi S.

Cancer. 2017 May 1;123(9):1516-1527. doi: 10.1002/cncr.30518. Epub 2017 Jan 24.

20.

The toll of not screening for colorectal cancer.

Chen C, Hoffmeister M, Brenner H.

Expert Rev Gastroenterol Hepatol. 2017 Jan;11(1):1-3. Epub 2016 Nov 29. No abstract available.

PMID:
27897033

Supplemental Content

Loading ...
Support Center